PETcision Guard

 

Category: Health/Treatment

Exhibitor: PETCISION CO., LTD.

Booth No: N1405

 

Characteristic

 

PETcision Guard is an advanced canine cancer genetic testing service developed by PETcision. Utilizing cutting-edge liquid biopsy and next-generation sequencing (NGS) technologies, this low-invasive test requires only a blood sample to detect over 100 cancer-associated genes. It can identify more than 20 types of canine cancers, including lymphoma, mammary tumors, mast cell tumors, and hemangiosarcoma, with a sensitivity of up to 90% and specificity of 99%.

The test is applicable across all stages of cancer management, from early screening and diagnosis aid to treatment evaluation and monitoring. Compared to traditional imaging methods, PETcision Guard can detect cancer signals 1–2 months earlier, providing veterinarians with crucial time for intervention.

Currently, over 100 veterinary clinics across Taiwan offer this testing service, providing pet owners with a safe, timely, and accurate method for cancer detection.

 

 

 

Back